IU School of Medicine research helps lead to FDA clearance of first blood test for Alzheimer’s disease
Business Announcement
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Updates every hour. Last Updated: 30-Oct-2025 10:11 ET (30-Oct-2025 14:11 GMT/UTC)
Late-life mood disorders (LLMDs), such as depression and bipolar disorder, appearing after 40 years of age, may signal early neurodegenerative diseases. Using advanced PET scans and autopsy data, researchers from Japan revealed that many patients with LLMDs exhibit abnormal tau and amyloid protein accumulation—key markers of dementia—years before cognitive symptoms arise. Their findings highlight tau-PET imaging as a promising tool for detecting underlying brain pathologies, paving the way to early dementia diagnosis.
By reprogramming brain cells, a new gene therapy approach for Alzheimer's developed by UC San Diego researchers could address the root cause of the disease to halt its progression.